DEFZATAS

Treatment of cancer, Treatment of Inflammatory conditions, Treatment of Autoimmune conditions, Treatment of Duchenne muscular dystrophy(DMD) Deflazacort oral suspension 6 mg / 5 mln belongs to a group of medicines known as corticosteroids. Its anti-inflammatory and immunosuppressive properties give it the ability to treat a wide range of conditions in children. It is also one of the primary medicines used for Duchenne muscular dystrophy in infants and children.